Skip to main content
. Author manuscript; available in PMC: 2018 Apr 18.
Published in final edited form as: Clin Cancer Drugs. 2017;4(2):122–128. doi: 10.2174/2212697x04666170817123425

Table 2.

Concomitant treatment administered with 5-FU.

Associated treatment n %
Cetuximab + Cisplatin 34 14.2
Cetuximab + Carboplatin 17 7.1
Cisplatin 106 44.2
Cisplatin + Taxol 50 20.8
Carboplatin 26 10.8
Other regimen (Gemcitabine, Dacarbazine, Cetuximab, Cisplatin, Carboplatin) 6 2.5
Not reported 1 0.4